Cancer Immune Control Needs Senescence Induction by Interferon-Dependent Cell Cycle Regulator Pathways in Tumours

Nature Communications - United Kingdom
doi 10.1038/s41467-020-14987-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

150 Cancer Immune Control Requires Interferon- Dependent Activation of the P16Ink4a Senescence Signaling Pathways

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Cancer: Tumours Aided by Immune Cells

Nature
Multidisciplinary
2010English

T H 1 Immune Signaling Induces Cancer Cell Senescence

Cancer Discovery
Oncology
2013English

Feedback Control of a Master Bacterial Cell-Cycle Regulator

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Correction: Optineurin Regulates the Interferon Response in a Cell Cycle-Dependent Manner

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2015English

PIN1 in Cell Cycle Control and Cancer

Frontiers in Pharmacology
Pharmacology
2018English

Cell-Cycle Regulator Cks1 Promotes Hepatocellular Carcinoma by Supporting NF- B-Dependent Expression of Interleukin-8

Cancer Research
Cancer ResearchOncology
2011English

Control of Cell Cycle Progression in Human Mesothelioma Cells Treated With Gamma Interferon

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

Immune Mechanisms and Possible Immune Therapy in Testicular Germ Cell Tumours

Andrology
EndocrinologyReproductive MedicineUrologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy